These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23591641)

  • 1. Prospects for prevention of Salmonella infection in children through vaccination.
    McGregor AC; Waddington CS; Pollard AJ
    Curr Opin Infect Dis; 2013 Jun; 26(3):254-62. PubMed ID: 23591641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines against invasive Salmonella disease: current status and future directions.
    MacLennan CA; Martin LB; Micoli F
    Hum Vaccin Immunother; 2014; 10(6):1478-93. PubMed ID: 24804797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated vaccines for invasive Salmonella infections.
    Tennant SM; Levine MM
    Vaccine; 2015 Jun; 33 Suppl 3(0 3):C36-41. PubMed ID: 25902362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S; Chowdhury R; Pal A; Okamoto K; Das S
    Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for typhoid fever and other salmonelloses.
    Martin LB
    Curr Opin Infect Dis; 2012 Oct; 25(5):489-99. PubMed ID: 22825288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Our Understanding of
    Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of paratyphoid fever vaccine research and development.
    Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
    Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
    Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
    Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.
    Boyd MA; Tennant SM; Saague VA; Simon R; Muhsen K; Ramachandran G; Cross AS; Galen JE; Pasetti MF; Levine MM
    Clin Vaccine Immunol; 2014 May; 21(5):712-21. PubMed ID: 24623629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the Nontyphoidal and Paratyphoidal Salmonella Vaccine Pipeline: Current Status and Future Prospects.
    Baliban SM; Lu YJ; Malley R
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S151-S154. PubMed ID: 32725233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
    Levine MM; Ferreccio C; Black RE; Lagos R; San Martin O; Blackwelder WC
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S24-8. PubMed ID: 17582564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.
    Wahid R; Fresnay S; Levine MM; Sztein MB
    Clin Immunol; 2016 Dec; 173():87-95. PubMed ID: 27634430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typhoid and paratyphoid fever: a clinical seminar.
    Manesh A; Meltzer E; Jin C; Britto C; Deodhar D; Radha S; Schwartz E; Rupali P
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33550411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
    Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
    Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
    Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
    mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.